SEC Filing Summary: AspenBio Pharma, Inc.
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on October 3, 2006. The registrant is incorporated in Colorado. The filing serves to report the issuance of a press release regarding the company's results of operations and financial condition.
Note: The request metadata references "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as "AspenBio Pharma, Inc." This summary reflects the content of the provided text.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that a press release containing these details was issued on October 3, 2006, and is attached as Exhibit 99.1.
Material Changes
The filing references Item 2.02 (Results of Operations and Financial Condition) but does not detail specific material changes or comparative data within the text provided. It states that the information in the referenced press release shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934.
Guidance, Outlook, and Risks
The text does not contain specific management commentary, forward-looking guidance, risk factors, or descriptions of unusual items. It solely confirms the existence of a press release dated October 3, 2006, which contains the relevant operational and financial updates.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific financial figures.
- Confirm the discrepancy between the request metadata (Riot Platforms, Inc.) and the filing registrant (AspenBio Pharma, Inc.).
- Note that the financial information in the press release is not incorporated by reference into this 8-K filing.